Clinical Trials for Pyoderma Gangrenosum

Find clinical trials for pyoderma gangrenosum. Discover research opportunities and treatment options in your area.

6 Active Trials Found

Showing 6 trials on this page

Page 1 of 1

A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum

NCT ID: NCT06624670

This clinical trial is studying a medication called spesolimab to see if it helps people with a skin condition known as pyoderma gangrenosum (PG). Specifically, the trial is looking to find out if ...

Recruiting

Phase: PHASE3 Type: interventional Locations: Tampa, Florida, United States, Philadelphia, Pennsylvania, United States +140 more

Phase III Trial to Investigate Efficacy and Safety of Vilobelimab in Ulcerative Pyoderma Gangrenosum

NCT ID: NCT05964413

This clinical trial is studying a new treatment called vilobelimab for people with a condition known as ulcerative pyoderma gangrenosum, which causes painful ulcers on the skin. The trial is in its...

Recruiting

Phase: PHASE3 Type: interventional Locations: Columbus, Ohio, United States, Boston, Massachusetts, United States +88 more

Spesolimab in Pyoderma Gangrenosum

NCT ID: NCT06092216

This clinical trial is studying a medication called spesolimab to see if it can help people with moderate to severe pyoderma gangrenosum (PG), a rare skin condition that causes painful ulcers. The ...

Recruiting

Phase: PHASE2 Type: interventional Locations: New York, New York, United States

Guselkumab in the Treatment of Adults With Pyoderma Gangrenosum (PG)

NCT ID: NCT06563323

This clinical trial is studying a medication called guselkumab to see how effective it is in treating adults with pyoderma gangrenosum (PG), a condition that causes painful skin ulcers. The study w...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Portland, Oregon, United States

Autologous Platelet-Rich Plasma Therapy in the Treatment of Pyoderma Gangrenosum

NCT ID: NCT05984654

This clinical trial is investigating a treatment called autologous Platelet-Rich Plasma (PRP) therapy for patients with pyoderma gangrenosum (PG), a condition that causes painful ulcers on the skin...

Recruiting

Phase: NA Type: interventional Locations: Columbus, Ohio, United States

A Novel Therapeutic Treatment of Pyoderma Gangrenosum

NCT ID: NCT05120726

This clinical trial is studying a new treatment for pyoderma gangrenosum, a serious skin condition that causes painful, non-healing wounds. The researchers believe that a product called EpiFix, mad...

Recruiting

Phase: PHASE4 Type: interventional Locations: New Orleans, Louisiana, United States, New Orleans, Louisiana, United States +1 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions